{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:36:38Z","timestamp":1793331398321,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1117079"],"award-info":[{"award-number":["1117079"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>There is growing evidence that neuroinflammation may contribute to schizophrenia neuropathology. Elevated pro-inflammatory cytokines are evident in the midbrain from schizophrenia subjects, findings that are driven by a subgroup of patients, characterised as a \u201chigh inflammation\u201d biotype. Cytokines trigger the release of antibodies, of which immunoglobulin G (IgG) is the most common. The level and function of IgG is regulated by its transporter (FcGRT) and by pro-inflammatory IgG receptors (including FcGR3A) in balance with the anti-inflammatory IgG receptor FcGR2B. Testing whether abnormalities in IgG activity contribute to the neuroinflammatory abnormalities schizophrenia patients, particularly those with elevated cytokines, may help identify novel treatment targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Post-mortem midbrain tissue from healthy controls and schizophrenia cases (<jats:italic>n<\/jats:italic>\u2009=\u200958 total) was used to determine the localisation and abundance of IgG and IgG transporters and receptors in the midbrain of healthy controls and schizophrenia patients. Protein levels of IgG and FcGRT were quantified using western blot, and gene transcript levels of FcGRT, FcGR3A and FcGR2B were assessed using qPCR. The distribution of IgG in the midbrain was assessed using immunohistochemistry and immunofluorescence. Results were compared between diagnostic (schizophrenia vs control) and inflammatory (high vs low inflammation) groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that IgG and FcGRT protein abundance (relative to \u03b2-actin) was unchanged in people with schizophrenia compared with controls irrespective of inflammatory subtype. In contrast, FcGRT and FcGR3A mRNA levels were elevated in the midbrain from \u201chigh inflammation\u201d schizophrenia cases (FcGRT;<jats:italic>p<\/jats:italic>\u2009=\u20090.02, FcGR3A;<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) in comparison to low-inflammation patients and healthy controls, while FcGR2B mRNA levels were unchanged. IgG immunoreactivity was evident in the midbrain, and approximately 24% of all individuals (control subjects and schizophrenia cases) showed diffusion of IgG from blood vessels into the brain. However, the intensity and distribution of IgG was comparable across schizophrenia cases and control subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings suggest that an increase in the pro-inflammatory Fc\u03b3 receptor FcGR3A, rather than an overall increase in IgG levels, contribute to midbrain neuroinflammation in schizophrenia patients. However, more precise information about IgG-Fc\u03b3 receptor interactions is needed to determine their potential role in schizophrenia neuropathology.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12974-022-02541-8","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T15:44:25Z","timestamp":1657899865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increased levels of a pro-inflammatory IgG receptor in the midbrain of people with schizophrenia"],"prefix":"10.1186","volume":"19","author":[{"given":"A.","family":"Petty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Rothmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Purves-Tyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Shannon","family":"Weickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"issue":"7","key":"2541_CR1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiat. 2011;70(7):663\u201371.","journal-title":"Biol Psychiat"},{"issue":"1","key":"2541_CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-017-0962-y","volume":"14","author":"D Boerrigter","year":"2017","unstructured":"Boerrigter D, Weickert TW, Lenroot R, O\u2019Donnell M, Galletly C, Liu D, et al. Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. J Neuroinflammation. 2017;14(1):188.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2541_CR3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","volume":"18","author":"SG Fillman","year":"2013","unstructured":"Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 2013;18(2):206\u201314.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"2541_CR4","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.238","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Catts VS, Sheedy D, McCrossin T, Kril JJ, Shannon WC. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl Psychiatry. 2016;6(12): e982.","journal-title":"Transl Psychiatry"},{"key":"2541_CR5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41380-019-0434-0","volume":"26","author":"TD Purves-Tyson","year":"2019","unstructured":"Purves-Tyson TD, Weber-Stadlbauer U, Richetto J, Rothmond DA, Labouesse MA, Polesel M, et al. Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation. Mol Psychiatry. 2019;26:849.","journal-title":"Mol Psychiatry"},{"key":"2541_CR6","first-page":"1","volume":"49","author":"TR Marques","year":"2018","unstructured":"Marques TR, Ashok AH, Pillinger T, Veronese M, Turkheimer FE, Dazzan P, et al. Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies. Psychol Med. 2018;49:1\u201311.","journal-title":"Psychol Med"},{"issue":"11","key":"2541_CR7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1176\/appi.ajp.2015.15010019","volume":"172","author":"DW Volk","year":"2015","unstructured":"Volk DW, Chitrapu A, Edelson JR, Roman KM, Moroco AE, Lewis DA. Molecular mechanisms and timing of cortical immune activation in schizophrenia. Am J Psychiatry. 2015;172(11):1112\u201321.","journal-title":"Am J Psychiatry"},{"key":"2541_CR8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41380-021-01149-3","volume":"26","author":"C Weissleder","year":"2021","unstructured":"Weissleder C, North HF, Bitar M, Fullerton JM, Sager R, Barry G, et al. Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia. Mol Psychiatry. 2021;26:688.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2541_CR9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41398-021-01742-8","volume":"11","author":"HF North","year":"2021","unstructured":"North HF, Weissleder C, Fullerton JM, Sager R, Webster MJ, Weickert CS. A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone. Transl Psychiatry. 2021;11(1):635.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"2541_CR10","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.8","volume":"4","author":"SG Fillman","year":"2014","unstructured":"Fillman SG, Sinclair D, Fung SJ, Webster MJ, Shannon WC. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry. 2014;4(2): e365.","journal-title":"Transl Psychiatry"},{"key":"2541_CR11","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3389\/fimmu.2020.02002","volume":"11","author":"TD Purves-Tyson","year":"2020","unstructured":"Purves-Tyson TD, Robinson K, Brown AM, Boerrigter D, Cai HQ, Weissleder C, et al. Increased macrophages and C1qA, C3, C4 transcripts in the midbrain of people with schizophrenia. Front Immunol. 2020;11:2002.","journal-title":"Front Immunol"},{"issue":"8","key":"2541_CR12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbi.2012.08.005","volume":"26","author":"S Busse","year":"2012","unstructured":"Busse S, Busse M, Schiltz K, Bielau H, Gos T, Brisch R, et al. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations? Brain Behav Immun. 2012;26(8):1273\u20139.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"2541_CR13","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.4049\/jimmunol.170.9.4497","volume":"170","author":"A Alter","year":"2003","unstructured":"Alter A, Duddy M, Hebert S, Biernacki K, Prat A, Antel JP, et al. Determinants of human B cell migration across brain endothelial cells. J Immunol. 2003;170(9):4497\u2013505.","journal-title":"J Immunol"},{"issue":"8","key":"2541_CR14","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.4049\/jimmunol.0903732","volume":"185","author":"O Steiner","year":"2010","unstructured":"Steiner O, Coisne C, Cecchelli R, Boscacci R, Deutsch U, Engelhardt B, et al. Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. J Immunol. 2010;185(8):4846\u201355.","journal-title":"J Immunol"},{"issue":"2","key":"2541_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117450","volume":"10","author":"JS Coley","year":"2015","unstructured":"Coley JS, Calderon TM, Gaskill PJ, Eugenin EA, Berman JW. Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis. PLoS ONE. 2015;10(2): e0117450.","journal-title":"PLoS ONE"},{"key":"2541_CR16","first-page":"761","volume":"25","author":"HQ Cai","year":"2018","unstructured":"Cai HQ, Catts VS, Webster MJ, Galletly C, Liu D, O\u2019Donnell M, et al. Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Mol Psychiatry. 2018;25:761.","journal-title":"Mol Psychiatry"},{"issue":"Pt 5","key":"2541_CR17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/brain\/awg118","volume":"126","author":"IC Anthony","year":"2003","unstructured":"Anthony IC, Crawford DH, Bell JE. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain. 2003;126(Pt 5):1058\u201367.","journal-title":"Brain"},{"key":"2541_CR18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbi.2020.04.021","volume":"88","author":"K Schlaaff","year":"2020","unstructured":"Schlaaff K, Dobrowolny H, Frodl T, Mawrin C, Gos T, Steiner J, et al. Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients. Brain Behav Immun. 2020;88:497\u2013506.","journal-title":"Brain Behav Immun"},{"key":"2541_CR19","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1126\/science.abf9277","volume":"373","author":"S Brioschi","year":"2021","unstructured":"Brioschi S, Wang WL, Peng V, Wang M, Shchukina I, Greenberg ZJ, et al. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders. Science. 2021;373:6553.","journal-title":"Science"},{"issue":"34","key":"2541_CR20","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1523\/JNEUROSCI.1671-13.2013","volume":"33","author":"ES Wohleb","year":"2013","unstructured":"Wohleb ES, Powell ND, Godbout JP, Sheridan JF. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J Neurosci. 2013;33(34):13820\u201333.","journal-title":"J Neurosci"},{"issue":"2","key":"2541_CR21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/pr.117.014647","volume":"70","author":"MA Erickson","year":"2018","unstructured":"Erickson MA, Banks WA. Neuroimmune axes of the blood-brain barriers and blood-brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions. Pharmacol Rev. 2018;70(2):278\u2013314.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"2541_CR22","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.172.4.2021","volume":"172","author":"RJ Ober","year":"2004","unstructured":"Ober RJ, Martinez C, Vaccaro C, Zhou J, Ward ES. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor. FcRn J Immunol. 2004;172(4):2021\u20139.","journal-title":"FcRn J Immunol"},{"issue":"2","key":"2541_CR23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0198-8859(00)00244-5","volume":"62","author":"F Antohe","year":"2001","unstructured":"Antohe F, Radulescu L, Gafencu A, Ghetie V, Simionescu M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol. 2001;62(2):93\u2013105.","journal-title":"Hum Immunol"},{"issue":"7","key":"2541_CR24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","volume":"104","author":"BL Dickinson","year":"1999","unstructured":"Dickinson BL, Badizadegan K, Wu Z, Ahouse JC, Zhu X, Simister NE, et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest. 1999;104(7):903\u201311.","journal-title":"J Clin Invest"},{"issue":"4","key":"2541_CR25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1365-2567.1996.d01-775.x","volume":"89","author":"EJ Israel","year":"1996","unstructured":"Israel EJ, Wilsker DF, Hayes KC, Schoenfeld D, Simister NE. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology. 1996;89(4):573\u20138.","journal-title":"Immunology"},{"issue":"7","key":"2541_CR26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.186.7.1027","volume":"186","author":"MT Crowley","year":"1997","unstructured":"Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F, Lowell C, et al. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J Exp Med. 1997;186(7):1027\u201339.","journal-title":"J Exp Med"},{"issue":"5","key":"2541_CR27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood.V85.5.1175.bloodjournal8551175","volume":"85","author":"ZK Indik","year":"1995","unstructured":"Indik ZK, Park JG, Pan XQ, Schreiber AD. Induction of phagocytosis by a protein tyrosine kinase. Blood. 1995;85(5):1175\u201380.","journal-title":"Blood"},{"issue":"3","key":"2541_CR28","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4049\/jimmunol.135.3.1981","volume":"135","author":"SS Sung","year":"1985","unstructured":"Sung SS. Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions. J Immunol. 1985;135(3):1981\u20136.","journal-title":"J Immunol"},{"issue":"9","key":"2541_CR29","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1128\/IAI.70.9.5177-5184.2002","volume":"70","author":"X Song","year":"2002","unstructured":"Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, Lee SC. Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. Infect Immun. 2002;70(9):5177\u201384.","journal-title":"Infect Immun"},{"issue":"2","key":"2541_CR30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2004-10-4100","volume":"106","author":"R Galandrini","year":"2005","unstructured":"Galandrini R, Micucci F, Tassi I, Cifone MG, Cinque B, Piccoli M, et al. Arf6: a new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity. Blood. 2005;106(2):577\u201383.","journal-title":"Blood"},{"issue":"6173","key":"2541_CR31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/333568a0","volume":"333","author":"D Simmons","year":"1988","unstructured":"Simmons D, Seed B. The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein. Nature. 1988;333(6173):568\u201370.","journal-title":"Nature"},{"issue":"1","key":"2541_CR32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004208","volume":"4","author":"T Joshi","year":"2009","unstructured":"Joshi T, Ganesan LP, Cheney C, Ostrowski MC, Muthusamy N, Byrd JC, et al. The PtdIns 3-kinase\/Akt pathway regulates macrophage-mediated ADCC against B cell lymphoma. PLoS ONE. 2009;4(1): e4208.","journal-title":"PLoS ONE"},{"issue":"8","key":"2541_CR33","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/MCB.17.8.4305","volume":"17","author":"S Tridandapani","year":"1997","unstructured":"Tridandapani S, Kelley T, Pradhan M, Cooney D, Justement LB, Coggeshall KM. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. Mol Cell Biol. 1997;17(8):4305\u201311.","journal-title":"Mol Cell Biol"},{"issue":"6597","key":"2541_CR34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/383263a0","volume":"383","author":"M Ono","year":"1996","unstructured":"Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature. 1996;383(6597):263\u20136.","journal-title":"Nature"},{"issue":"4","key":"2541_CR35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1753425917701553","volume":"23","author":"T Segawa","year":"2017","unstructured":"Segawa T, Hazeki K, Nigorikawa K, Nukuda A, Tanizawa T, Miyamoto K, et al. Inhibitory receptor FcgammaRIIb mediates the effects of IgG on a phagosome acidification and a sequential dephosphorylation system comprising SHIPs and Inpp4a. Innate Immun. 2017;23(4):401\u20139.","journal-title":"Innate Immun"},{"issue":"1","key":"2541_CR36","volume":"7","author":"TD Purves-Tyson","year":"2017","unstructured":"Purves-Tyson TD, Owens SJ, Rothmond DA, Halliday GM, Double KL, Stevens J, et al. Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain. Transl Psychiatry. 2017;7(1): e1003.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"2541_CR37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00048670903393662","volume":"44","author":"CS Weickert","year":"2010","unstructured":"Weickert CS, Sheedy D, Rothmond DA, Dedova I, Fung S, Garrick T, et al. Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry. 2010;44(1):59\u201370.","journal-title":"Aust N Z J Psychiatry"},{"issue":"8","key":"2541_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.134","volume":"7","author":"LJ Glass","year":"2017","unstructured":"Glass LJ, Sinclair D, Boerrigter D, Naude K, Fung SJ, Brown D, et al. Brain antibodies in the cortex and blood of people with schizophrenia and controls. Transl Psychiatry. 2017;7(8): e1192.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"2541_CR39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbrc.2010.10.020","volume":"402","author":"S Gupta","year":"2010","unstructured":"Gupta S, Booth JW. ERK phosphorylation and tumor necrosis factor-alpha production by monocytes are persistent in response to immobilized IgG. Biochem Biophys Res Commun. 2010;402(2):301\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2541_CR40","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.4049\/jimmunol.178.5.3272","volume":"178","author":"K Su","year":"2007","unstructured":"Su K, Yang H, Li X, Li X, Gibson AW, Cafardi JM, et al. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J Immunol. 2007;178(5):3272\u201380.","journal-title":"J Immunol"},{"issue":"9","key":"2541_CR41","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1084\/jem.20051503","volume":"203","author":"M Mackay","year":"2006","unstructured":"Mackay M, Stanevsky A, Wang T, Aranow C, Li M, Koenig S, et al. Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med. 2006;203(9):2157\u201364.","journal-title":"J Exp Med"},{"issue":"3","key":"2541_CR42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2567.2009.03138.x","volume":"128","author":"LJ Carreno","year":"2009","unstructured":"Carreno LJ, Pacheco R, Gutierrez MA, Jacobelli S, Kalergis AM. Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fc gamma receptors and costimulatory molecules on dendritic cells. Immunology. 2009;128(3):334\u201341.","journal-title":"Immunology"},{"issue":"3","key":"2541_CR43","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1074\/jbc.M115.684795","volume":"291","author":"AK Chauhan","year":"2016","unstructured":"Chauhan AK, Moore TL, Bi Y, Chen C. FcgammaRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression. J Biol Chem. 2016;291(3):1368\u201386.","journal-title":"J Biol Chem"},{"issue":"Pt 11","key":"2541_CR44","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","volume":"128","author":"CF Orr","year":"2005","unstructured":"Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM. A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease. Brain\u202f: a journal of neurology. 2005;128(Pt 11):2665\u201374.","journal-title":"Brain : a journal of neurology"},{"key":"2541_CR45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.18.1.739","volume":"18","author":"V Ghetie","year":"2000","unstructured":"Ghetie V, Ward ES. Multiple roles for the major histocompatibility complex class I- related receptor FcRn. Annu Rev Immunol. 2000;18:739\u201366.","journal-title":"Annu Rev Immunol"},{"issue":"1\u20132","key":"2541_CR46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0165-5728(01)00242-9","volume":"114","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Pardridge WM. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol. 2001;114(1\u20132):168\u201372.","journal-title":"J Neuroimmunol"},{"issue":"Pt 11","key":"2541_CR47","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awt264","volume":"136","author":"OD Howes","year":"2013","unstructured":"Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain. 2013;136(Pt 11):3242\u201351.","journal-title":"Brain"},{"issue":"8","key":"2541_CR48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104619","volume":"9","author":"Y Watanabe","year":"2014","unstructured":"Watanabe Y, Tanaka H, Tsukabe A, Kunitomi Y, Nishizawa M, Hashimoto R, et al. Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia. PLoS ONE. 2014;9(8): e104619.","journal-title":"PLoS ONE"},{"issue":"1","key":"2541_CR49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1742-2094-9-203","volume":"9","author":"PJ Gaskill","year":"2012","unstructured":"Gaskill PJ, Carvallo L, Eugenin EA, Berman JW. Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflammation. 2012;9(1):203.","journal-title":"J Neuroinflammation"},{"key":"2541_CR50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fncel.2018.00309","volume":"12","author":"Y Fan","year":"2018","unstructured":"Fan Y, Chen Z, Pathak JL, Carneiro AMD, Chung CY. Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine. Front Cell Neurosci. 2018;12:309.","journal-title":"Front Cell Neurosci"},{"issue":"21","key":"2541_CR51","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1523\/JNEUROSCI.21-21-08447.2001","volume":"21","author":"W-D Le","year":"2001","unstructured":"Le W-D, Rowe D, Xie W, Ortiz I, He Y, Appel SH. Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson\u2019s Disease. J Neurosci. 2001;21(21):8447\u201355.","journal-title":"J Neurosci"},{"issue":"2","key":"2541_CR52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41386-018-0151-4","volume":"44","author":"W Xin","year":"2019","unstructured":"Xin W, Schuebel KE, Jair KW, Cimbro R, De Biase LM, Goldman D, et al. Ventral midbrain astrocytes display unique physiological features and sensitivity to dopamine D2 receptor signaling. Neuropsychopharmacology. 2019;44(2):344\u201355.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"2541_CR53","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1073\/pnas.98.4.1964","volume":"98","author":"ZU Khan","year":"2001","unstructured":"Khan ZU, Koulen P, Rubinstein M, Grandy DK, Goldman-Rakic PS. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci USA. 2001;98(4):1964\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2541_CR54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0006-3223(99)00282-6","volume":"47","author":"M Akil","year":"2000","unstructured":"Akil M, Edgar CL, Pierri JN, Casali S, Lewis DA. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol Psychiat. 2000;47(5):361\u201370.","journal-title":"Biol Psychiat"},{"issue":"2","key":"2541_CR55","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.125","volume":"4","author":"A Vercammen","year":"2014","unstructured":"Vercammen A, Weickert CS, Skilleter AJ, Lenroot R, Schofield PR, Weickert TW. Common polymorphisms in dopamine-related genes combine to produce a \u201cschizophrenia-like\u201d prefrontal hypoactivity. Transl Psychiatry. 2014;4(2): e356.","journal-title":"Transl Psychiatry"},{"issue":"4","key":"2541_CR56","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamapsychiatry.2014.2414","volume":"72","author":"M Slifstein","year":"2015","unstructured":"Slifstein M, van de Giessen E, Van Snellenberg J, Thompson JL, Narendran R, Gil R, et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiat. 2015;72(4):316\u201324.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"2541_CR57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63\u201374.","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02541-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02541-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02541-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T18:17:47Z","timestamp":1676139467000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02541-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2541"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02541-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of post-mortem human brain tissue was approved by the University of New South Wales Human Research Ethics Committee (HC17826).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YK, SK and MM are employees of Astellas Pharma Inc and CSW is in collaboration with Astellas Pharma Inc. The authors declare no other conflicts of interest pertaining to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}